Down-regulation of NR2B receptors partially contributes to analgesic effects of Gentiopicroside in persistent inflammatory pain

详细信息    查看全文

• 作者：Lei Chen ; Jin-cheng Liu ; Xiao-nan Zhang ; Yan-yan Guo ; Zhao-hui Xu ; Wei Cao ; Xiao-li Sun ; Wen-ji Sun ; Ming-Gao Zhao
• 关键词：Gentiopicroside ; Inflammation ; Pain ; NMDA receptor ; Anterior cingulate cortex
• 刊名：Neuropharmacology
• 出版年：2008
• 出版时间：June 2008
• 年：2008
• 卷：54
• 期：8
• 页码：1175-1181
• 全文大小：784 K

文摘

Gentiopicroside is one of the secoiridoid compound isolated from Gentiana lutea. It exhibits analgesic activities in the mice. The anterior cingulate cortex (ACC) is a forebrain structure known for its roles in pain transmission and modulation. Painful stimuli potentiate the prefrontal synaptic transmission and induce glutamate NMDA NR2B receptor expression in the ACC. But little is known about Gentiopicroside on the persistent inflammatory pain and chronic pain-induced synaptic transmission changes in the ACC. The present study was undertaken to investigate its analgesic activities and central synaptic modulation to the peripheral painful inflammation. Gentiopicroside produced significant analgesic effects against persistent inflammatory pain stimuli in mice. Systemic administration of Gentiopicroside significantly reversed NR2B over-expression during the chronic phases of persistent inflammation caused by hind-paw administration of complete Freunds adjuvant (CFA) in mice. Whole-cell patch clamp recordings revealed that Gentiopicroside significantly reduced NR2B receptors mediated postsynaptic currents in the ACC. Our findings provide strong evidence that analgesic effects of Gentiopicroside involve down-regulation of NR2B receptors in the ACC to persistent inflammatory pain.